Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/30/2014US8846701 Pyrazolo-quinazolines
09/30/2014US8846700 Heteroaryl quinazoline derivatives
09/30/2014US8846699 Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof
09/30/2014US8846698 Pyrrolo[2,3-d]pyrimidine tropomysin-related kinase inhibitors
09/30/2014US8846697 Purine analogs
09/30/2014US8846696 Purine derivatives
09/30/2014US8846695 Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor
09/30/2014US8846694 Pyrrolidone derivatives for use as MetAP-2 inhibitors
09/30/2014US8846693 Optionally substituted pyrazolo[3,4-d]pyrimidine-4,6-diones
09/30/2014US8846692 Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
09/30/2014US8846691 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
09/30/2014US8846690 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
09/30/2014US8846688 Sodium channel blockers
09/30/2014US8846687 Pyrazine compounds as PI3 kinase inhibitors
09/30/2014US8846686 Compounds useful as inhibitors of ATR kinase
09/30/2014US8846685 Human protein tyrosine phosphatase inhibitors and methods of use
09/30/2014US8846684 Arbovirus inhibitors and uses thereof
09/30/2014US8846682 Compound suitable for the treatment of synucleopathies
09/30/2014US8846681 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
09/30/2014US8846680 Pharmaceutical composition comprising pimobendan
09/30/2014US8846679 Pharmaceutical composition comprising pimobendan
09/30/2014US8846678 Pyridazine derivatives and use thereof as medicaments for treating microRNA viral infection
09/30/2014US8846677 Medicaments
09/30/2014US8846676 6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof
09/30/2014US8846675 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
09/30/2014US8846674 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/30/2014US8846673 Azaindazoles as kinase inhibitors and use thereof
09/30/2014US8846672 Imidazopyridines as respiratory syncytial virus antiviral agents
09/30/2014US8846671 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
09/30/2014US8846670 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
09/30/2014US8846669 Oxazolidinone derivative and medical composition containing same
09/30/2014US8846668 Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
09/30/2014US8846667 Compounds for modulating integrin CD11b/CD18
09/30/2014US8846666 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
09/30/2014US8846665 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivative and pharmaceutical composition containing the same as neuromuscular blocker or skeletal muscle relaxant, and method for the preparation
09/30/2014US8846664 Pyrazinopyrazines and derivatives as kinase inhibitors
09/30/2014US8846663 Modulators of 5-HT receptors and methods of use thereof
09/30/2014US8846662 Benzodiazepine and/or pharmaceutical composition comprising benzodiazepine derivatives
09/30/2014US8846661 Diazahomoadamantane derivatives and methods of use thereof
09/30/2014US8846660 Seven-membered ring compound and pharmaceutical use therefor
09/30/2014US8846659 HIV integrase inhibitors
09/30/2014US8846657 Substituted imidazopyridines as HDM2 inhibitors
09/30/2014US8846655 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
09/30/2014US8846654 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
09/30/2014US8846653 Delta-tocotrienol treatment and prevention of pancreatic cancer
09/30/2014US8846652 Therapeutic uses of steroidal compounds
09/30/2014US8846651 Lipid composition having excellent shape retention property and product
09/30/2014US8846650 Method of treating middle ear infections
09/30/2014US8846649 Natural combination hormone replacement formulations and therapies
09/30/2014US8846648 Natural combination hormone replacement formulations and therapies
09/30/2014US8846647 C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
09/30/2014US8846646 Topical treatment of skin infection
09/30/2014US8846645 Cyclohexane compounds and their use as antibiotics
09/30/2014US8846644 Phosphate-containing nanoparticle delivery vehicle
09/30/2014US8846643 Phosphonates with reduced toxicity for treatment of viral infections
09/30/2014US8846642 Nutritional composition containing oligosaccharide mixture
09/30/2014US8846641 Stabilized ophthalmic galactomannan formulations
09/30/2014US8846639 Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity
09/30/2014US8846638 Macrocyclic nucleoside phosphoramidate derivatives
09/30/2014US8846637 Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
09/30/2014US8846636 Nucleoside analogues with quaternary carbon stereogenic centers and methods of use
09/30/2014US8846635 Method for inducing hepatocyte proliferation and uses thereof
09/30/2014US8846633 Method for inhibiting cancer stem cell like properties and chemoradioresistant properties of cancer or tumor cells with microRNA145
09/30/2014US8846630 Pharmaceutical composition for treating cancer
09/30/2014US8846628 Oral formulations of cytidine analogs and methods of use thereof
09/30/2014US8846627 Method for treatment of malaria
09/30/2014US8846626 Drug composition for treating chronic liver disease and its application
09/30/2014US8846623 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
09/30/2014US8846620 Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
09/30/2014US8846613 Pharmaceutical combinations for the treatment of metabolic disorders
09/30/2014US8846612 Promotion of healthy catch-up growth
09/30/2014US8846609 Leukotoxin E/D as a new anti-inflammatory agent and microbicide
09/30/2014US8846606 Method and drug composition for treating septic shock hypotension
09/30/2014US8846604 Lipid compositions with high DHA content
09/30/2014US8846602 Process for producing an injectable medicament preparation
09/30/2014US8846600 Carboxamide compounds and methods for using the same
09/30/2014US8846569 Pesticidal bis-organosulfur compounds
09/30/2014US8846401 Promoters exhibiting endothelial cell specificity and methods of using same
09/30/2014US8846321 Association of levels of HDL-cholesterol apolipoprotein CIII with the risk of coronary heart disease and cardiovascular events
09/30/2014US8846315 Disease risk factors and methods of use
09/30/2014US8846118 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
09/30/2014US8846115 Anti-inflammatory cyclooxygenase inhibitors
09/30/2014US8846114 Composition for the treatment of herpes and cold sores
09/30/2014US8846113 Method for treatment of diarrhea-predominant irritable bowel syndrome
09/30/2014US8846112 Methods of distributing a pharmaceutical product comprising nitric oxide gas for inhalation
09/30/2014US8846110 Polymeric systems for the delivery of anticancer drugs
09/30/2014US8846109 Treatment solution for treating wounds, in particular for liquid wound treatment
09/30/2014US8846106 Enhanced transport using membrane disruptive agents
09/30/2014US8846104 Pharmaceutical compositions for the deterrence and/or prevention of abuse
09/30/2014US8846100 Controlled dose drug delivery system
09/30/2014US8846096 Nanoparticles and methods of use
09/30/2014US8846095 Dextran-based polymer tissue adhesive for medical use
09/30/2014US8846094 Peripherally administered viscous formulations
09/30/2014US8846093 Adhesive mixture for transdermal delivery of highly plasticizing drugs
09/30/2014US8846092 Gum resin as a carrier for topical application of pharmacologically active agents
09/30/2014US8846091 Matrix for sustained, invariant and independent release of active compounds
09/30/2014US8846090 Matrix for sustained, invariant and independent release of active compounds
09/30/2014US8846086 Tamper resistant dosage forms
09/30/2014US8846085 Method for production of directly compressible ibuprofen formulations
09/30/2014US8846084 Controlled release compositions containing zolpidem
1 ... 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 ... 7860